Transmutex SA, a Geneva-Based Company, Raises Over CHF 20 Mi

Transmutex SA, a nuclear engineering company based in Geneva, Switzerland, announces a new round of financing to further develop its pivotal solution to a safer, lower-cost, proliferation-resistant nuclear energy technology. The Series A2 round is co-led by Union Square Ventures and Steel Atlas.

Related Keywords

New York , United States , Italy , United Kingdom , Geneva , Genè , Switzerland , France , China , Monte Carlo , Toscana , Canton , Talal Attieh , Giovanni Anelli , Albert Wenger , Cameron Porter , Helen Lin , Laura Thomson , Franklin Servan Schreiber , Ansaldo Nucleare , Antonio Gambardella , Union Square Ventures , National Center , Ipcc , International Collaborations With Leaders In Nuclear Energy , Subcritical Transmuting Accelerated Regenerative Technology , Partner At Union Square Ventures , United Nations , Tiny Supercomputer Investment Co , Research Facility , Argonne National Laboratory , Polytechnic Institute Of Lausanne , Scientific Research , Paul Scherrer Institute , Subcritical Transmuting Accelerated Regenerative , Managing Partner , Union Square , Steel Atlas , Square Ventures , House Of Ventures , Presight Capital , Verve Ventures , Tiny Supercomputer Investment , More Technical Roles , New Research , International Collaborations With Leaders , Polytechnic Institute , First Approach , Lower Cost Engineering ,